Cargando…
Liraglutide Protects Against Brain Amyloid-β(1–42) Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
Alzheimer’s disease (AD) is the most common form of dementia worldwide, being characterized by the deposition of senile plaques, neurofibrillary tangles (enriched in the amyloid beta (Aβ) peptide and hyperphosphorylated tau (p-tau), respectively) and memory loss. Aging, type 2 diabetes (T2D) and fem...
Autores principales: | Duarte, Ana I., Candeias, Emanuel, Alves, Inês N., Mena, Débora, Silva, Daniela F., Machado, Nuno J., Campos, Elisa J., Santos, Maria S., Oliveira, Catarina R., Moreira, Paula I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084254/ https://www.ncbi.nlm.nih.gov/pubmed/32143329 http://dx.doi.org/10.3390/ijms21051746 |
Ejemplares similares
-
Oxidative and Nitrosative Stress in the Metastatic Microenvironment
por: Ortega, Ángel L., et al.
Publicado: (2010) -
Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
por: Sebastião, Inês, et al.
Publicado: (2014) -
Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease
por: Duarte, Ana I., et al.
Publicado: (2018) -
secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids
por: De Mena, Lorena, et al.
Publicado: (2017) -
Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
por: Jantrapirom, Salinee, et al.
Publicado: (2020)